BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 6201026)

  • 21. [Immunological criteria for using thymus preparations and tuberculin therapy in the combined treatment of patients with tuberculosis].
    Knoring BE; Vasil'ev AV; Sakharova IIa; Machkova NA; Ivanova LA
    Probl Tuberk; 1988; (3):27-31. PubMed ID: 3260381
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunological dysfunctions in multiple sclerosis. I. Diminution of 'active' thymus-derived lymphocytes and presence of immunomodulating serum factors.
    Kateley JR; Bazzell SJ
    Clin Exp Immunol; 1979 Feb; 35(2):218-26. PubMed ID: 312171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Increase in the efficacy of corticosteroid therapy in multiple sclerosis].
    Golovkin VI; Chikov Miu
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(8):1131-4. PubMed ID: 3876669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of synthetic thymic hormone (TP5) in children with T-cell immunodeficiencies.
    Levinsky RJ; Davies EG; Goldstein G
    Birth Defects Orig Artic Ser; 1983; 19(3):273-6. PubMed ID: 6360239
    [No Abstract]   [Full Text] [Related]  

  • 25. [Principles of immunocorrective therapy using the thymus preparation T-activin].
    Arion VIa; Ivanushkin EF
    Khirurgiia (Mosk); 1984 Nov; (11):44-8. PubMed ID: 6335205
    [No Abstract]   [Full Text] [Related]  

  • 26. [Mechanism of formation of active T-rosette forming cells in multiple sclerosis patients].
    Matveeva TV; D'iakonova IN; Shaĭdullina FS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(2):21-5. PubMed ID: 6972132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effectiveness of immunostimulants in nonspecific ulcerative colitis].
    Perederiĭ VG; Tkach SM; Bychkova NG; Blazhenko IL
    Sov Med; 1990; (4):17-9. PubMed ID: 2374965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Secondary immunodeficiency and its correction with thymus preparations in patients with postabortion endometritis].
    Franchuk AE; Benzar ZT
    Akush Ginekol (Mosk); 1990 Sep; (9):40-3. PubMed ID: 2278306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The thymic hormones].
    Romero M; Tognoni G
    Riv Inferm; 1988 Mar; 7(1):37-48. PubMed ID: 3135577
    [No Abstract]   [Full Text] [Related]  

  • 30. Therapy with thymopoietin pentapeptide (TP-5) in 26 patients with primary immunodeficiencies.
    Aiuti F; Businco L; Fiorilli M; Galli E; Quinti I; Le Moli S; Seminara R; Goldstein G
    Birth Defects Orig Artic Ser; 1983; 19(3):267-72. PubMed ID: 6360238
    [No Abstract]   [Full Text] [Related]  

  • 31. [The effect of thymalin on the count of large granular lymphocytes in the peripheral blood of mice with leukemia P388].
    Potapov IuN; Khaleev DV; Krutova TV; Pashkova VS
    Izv Akad Nauk SSSR Biol; 1991; (1):133-5. PubMed ID: 1856357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunological profile in sarcoidosis patients. The in vitro and in vivo effect of thymic humoral factor.
    Shohat B; Spitzer S; Topilsky M; Trainin N
    Biomedicine; 1978 May; 29(3):91-5. PubMed ID: 28795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical impressions on the treatment of multiple sclerosis with thymus factor.
    Cendrowski W
    Schweiz Arch Neurol Neurochir Psychiatr; 1980; 127(2):199-203. PubMed ID: 6169140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prospects of using immunocorrective treatment with an active thymus factor (taktivin) in dermatology].
    Skripkin IuK; Korotkiĭ NG; Udzhukhu VIu; Arion VIa; Eletskiĭ AIu
    Vestn Dermatol Venerol; 1986; (4):4-7. PubMed ID: 3487189
    [No Abstract]   [Full Text] [Related]  

  • 35. [A cytomorphological basis for the correction of radiation-induced immunodeficiencies and hematopoietic depression using thymus and bone marrow peptides].
    Khmel'nitskiĭ OK; Grintsevich II; Kotov VA; Seryĭ SV
    Arkh Patol; 1993; 55(2):50-3. PubMed ID: 7980063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of thymalin on the thymus and immunologic indices of irradiated animals].
    Grintsevich II; Morozov VG; Khavinson VKh; Seryĭ SV
    Radiobiologiia; 1984; 24(4):537-40. PubMed ID: 6548035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thymostimulin in the antiinfectious treatment in patients with burns.
    Schiavon M; Chiarelli A; Löhr G; Mazzoleni F
    Arzneimittelforschung; 1987 May; 37(5):557-60. PubMed ID: 3497638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Concepts of stimulating immunotherapy].
    Aiuti F; Montella F
    Minerva Med; 1982 Apr; 73(15):895-8. PubMed ID: 6176915
    [No Abstract]   [Full Text] [Related]  

  • 39. [Immunological correction in progressive pulmonary tuberculosis].
    Maslennikov AA; Kamenev VF; Kolomiets VM
    Probl Tuberk Bolezn Legk; 2007; (9):30-3. PubMed ID: 18038603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immune reactivity of patients with pulmonary tuberculosis suffering from chronic alcoholism].
    Mel'nik VP
    Vrach Delo; 1989 Apr; (4):82-5. PubMed ID: 2787943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.